Legal Opinion

In re Proton-Pump Inhibitor Products Liability Litigation

United States Judicial Panel on Multidistrict Litigation

Decided February 2, 2017No. MDL No. 2757Published

1Opinion of the Court

ORDER DENYING TRANSFER

SARAH S. VANCE, Chair

Before the Panel: Plaintiffs in six actions 1 move .to centralize fifteen actions in the Middle District of Louisiana (or, in the alternative, the District of New Jersey, the Southern District of Illinois, the District of Kansas, or the Western District of Louisiana). The.fifteen actions are listed on the attached Schedule A. The Panel has been informed of an additional 24 related federal actions.

All responding plaintiffs support centralization, although there is some disagreement concerning an appropriate transferee district. Some plaintiffs support…

2Cases cited6 opinions

  1. In re Watson Fentanyl Patch Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
  2. In re Yellow Brass Plumbing Component Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2012
  3. In Re Ambulatory Pain-Pumpchondrolysis Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2010
  4. In re Invokana (CANAGLIFLOZIN) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2016
  5. In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2013

1 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API